Therapeutic intervention for SEPN1-RM is currently limited to palliative measures; incomplete understanding of its molecular mechanism and lack of biomarkers hinder therapeutic development in this rare genetic disease.21 The gene discussed is SELENON; the disease is hereditary disease.